Tuesday, December 27, 2011

Texas A&M Football Player Killed in Crash With 18-Wheeler

Texas A&M University was Thursday mourning the loss of an Aggie football player, 22-year-old Joseph Villavisencio.

Villavisencio was killed in a head-on collision on Highway 39, south of Normangee -- about 115 miles north of Houston Thursday according to an A&M statement cited by myFOXhouston.com.

The senior offensive lineman was on his way home to Jacksonville, Texas, when according to witnesses, he swerved to avoid a buzzard on the roadway and went directly into the path of an oncoming 18-wheeler.

"Villavisencio played his freshman season in 2008 earning his first career start on the offensive line in a 49-35 A&M victory against Iowa State in Ames, Iowa," the A&M statement read.

During his Jacksonville High School years, he earned second team all-state honors from the Associated Press and the Texas Sports Writers Association.  A senior radiological health engineering major, Villavisencio is survived by his sister, mother and father.  The driver of the 18-wheeler was not hurt, KBTX-TV reported.

Wednesday, December 21, 2011

Earlier, more comprehensive Honda recall could have avoided near fatal injury

TOKYO — Georgia college student Kristy Williams was almost killed when a metal piece flew out of an air bag in her 2001 Honda Civic — a traumatic accident her lawyer says might have been avoided had there been an earlier, more comprehensive recall.

Williams had even arranged to get her air bag fixed. But the appointment was a week too late.

The recalls at Honda Motor Co. for defective air bags that may inflate with too much pressure and send pieces of metal and plastic flying now affect some 2 million vehicles around the world.

Tragically for Williams, although recalls for air bags began in November 2008, her vehicle wasn’t included until last year’s batch.

The Tokyo-based automaker has now issued five recalls for defective air bags — the latest just this month for 304,000 vehicles globally, including the popular Accord, Civic, Odyssey, Pilot, CR-V and other models manufactured in 2001 and 2002.

There have been 20 accidents related to the problems, including two deaths in the U.S. in 2009, according to Honda.

“This is a serious, basic problem,” Williams’ attorney Leigh May said in a telephone interview.

Honda should have made the recalls encompassing, and her client might not have gotten hurt if it had, she said.

“It’s so terrible. Air bags are supposed to be there to protect you. And, if the air bag is a mechanism of your injury, that’s just not right,” May told The Associated Press.

Honda and Williams settled for an amount that cannot be disclosed as a condition of their agreement, May said.

On April 2 last year, Williams was stopped at a traffic light when the driver and passenger air bags deployed without there being a crash.

Flying shrapnel severed her neck artery. She was in intensive care for two weeks, required several surgeries and suffered strokes. Luckily, she survived.

“It was really hard to get things together when I was released from the hospital. However, I am a determined individual and put my mind to finishing school,” Williams, 25, said in an email.

“I want others to be aware of the consequences of not getting the recall seen about ASAP,” she said.

Atlanta-based Butler, Wooten & Fryhofer, where May is a partner, is among a handful of U.S. law firms that won in suing Honda over the air bags.

May said it was unclear what Honda knew when, and why all the vehicles weren’t recalled the first time as the problem air bags came from one supplier, Takata Corp.

Honda spokesman Hajime Kaneko confirmed the recalled air bags came from the one supplier. Takata declined comment.

As it played out, the recalls grew almost piecemeal, from the first recall in 2008, to include more models in two separate recalls in 2009, and again last year, and then this month.

Kaneko said Honda had earlier thought the causes were different, such as the use of incorrect material in the chemical used to deploy the air bags and excessive moisture in the inflator propellant, which is part of what inflates the air bag.

But Honda found, under its fourth recall, that the cause was a defect during the production of the chemical, which had led to all the problems, Kaneko said. The latest recall came about because the company had not fully accounted for all the vehicles requiring recall, he said.

Honda, a reputed pioneer in air-bag technology, had expanded the recall to account for a possibly defective stamping machine during production.

“I can only say we are extremely sorry,” said Kaneko. “It is our responsibility we failed to identify a problem part in our products.”

_____________
source: Washington Post (Kageyama, 12/20)

Tuesday, December 13, 2011

Novartis Confirms Patient Died After Starting Gilenya (fingolimod)

Novartis AG (NOVN) said a multiple sclerosis patient died on Nov. 23 after starting treatment with Gilenya, the first pill approved to treat the debilitating neurological disease.

Whether Gilenya played a role in the patient’s death can’t be excluded or confirmed, Eric Althoff, a spokesman for the Basel, Switzerland-based drugmaker, said today in an e-mailed statement. The death is the first reported within 24 hours of the first Gilenya dose in more than 28,000 patients who have taken the drug, Althoff said.

Gilenya was approved in the U.S. last year and cleared for sale in Europe in March. It’s among the products Novartis is depending on to boost sales as patents start to expire on the company’s best-selling drugs, including the hypertension pill Diovan. It’s not clear yet how a single death might affect doctors’ cost-benefit analysis of the drug, Tim Anderson, an analyst for Sanford C. Bernstein Ltd., wrote in a note to investors today.

“In the case of MS drugs, there is often significant safety baggage of different sorts,” Anderson wrote. He rates Novartis’s shares “outperform” and estimates that by 2015 Gilenya sales will reach $1.4 billion, about 2 percent of the Swiss company’s revenue.

The exact cause of the death hasn’t been established, Novartis said. Sudden death “smacks of being cardiovascular in nature,” Anderson wrote, adding that the possibility of a temporary slowdown in heart rate after patients start treatment with Gilenya is part of the reason for a recommendation for monitoring in a doctor’s office after treatment begins.

The patient who died had begun treatment on Nov. 22 and had been monitored “without incident” for six hours after taking the first dose, Althoff said.

Novartis said it has sent details of the case to the U.S. Food and Drug Administration and other regulatory authorities.

________________
source: Bloomberg.com (Kresge, 12/13)



The Cole Law Group has a proven track record of obtaining substantial insurance settlements and jury awards for people hurt by prescription errors.

Let our experience, commitment and drive work to get you the money you deserve to rebuild your life. Our commitment to you: We will not be out worked!

Contact us today for a free consultation.

Tuesday, December 6, 2011

Three Dallas Police Officers Injured in 2 Traffic Accidents

Video KDAF TV - Three Dallas Police Officers Injured in 2 Traffic Accidents

Three DPD officers were sent to the hospital after they were involved in two differnt traffic accidents early Friday morning.
The first accident occurred around 2:00 am in the east-bound lanes of LBJ Freeway after a vehicle lost control and hit the center lane barrier. Two police squad cars were parked on the highway working the accident when an 18-wheeler jack-knifed into the vehicles. Two officers were transported to Parkland Hospital with unknown injuries.
Within an hour, a second similar accident occurred when another DPD vehicle was rear-ended by a car that was unable to stop on the slick road. The impact caused the squad car's gasoline tank to rupture, closing the freeway for HAZMAT clean up. One officer was taken to Parkland hospital for observation and the driver of the vehicle was uninjured.

Source - KDAF TV The cw33.com